dm+d

320067009

Lactation Safety Information

Milrinone, Digoxin
Phosphodiesterase type-3 inhibitor
No published evidence of safety
Avoid breastfeeding for 24 hours after a maternal dose
Used in full-term neonates from birth
18 March 2017